This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Anabolic steroids and hepatic effects

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Hepatic:

  • various abnormal liver function tests (elevated alkaline phosphatase, aminotransferases, conjugated bilirubin, and plasma proteins) have been associated with the use of anabolic androgenic steroids (AAS)

  • jaundice occasionally occurs as a result of hypersensitivity-type reaction and is usually seen after 2-5 months of therapy

  • cholestasis has been reported especially with the use of 17alpha-alkylated agents

  • in the majority of cases, the rise in transaminases is transient, with levels normalizing within a few weeks of discontinuation of AAS

  • peliosis hepatis and hepatocellular adenomas have been seen with the use of 17alpha-alkylated AAS

Reference:

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.